Results 181 to 190 of about 313,837 (264)

The Successful Use of Noninvasive Ventilation in Severe Asthma Exacerbation: A Case Report and Review of the Literature. [PDF]

Cureus
Gharti SB, Tan EFS, Schmidt M.
europepmc   +1 more source

DERMACLEAR: AI‐Powered Insights Into Four Chronic Inflammatory Skin Diseases in Spain

JEADV Clinical Practice, EarlyView.
Using an AI‐enhanced analysis of electronic health records from nearly 50,000 patients, the DERMACLEAR study provides real‐world insights into the prevalence, clinical complexity, comorbidities and treatment patterns of HS, CU, PsO and AD in Spain.
Ana Giménez‐Arnau, Javier Ortiz de Frutos, Raquel Rivera‐Díaz, Lluís Puig, Jaume Notario Rosa, José Luis López‐Estebaranz, Vicente García‐Patos Briones, Ana Martín‐Santiago, José Ignacio Rojo‐Laguna, Elisabet Fernández‐Martínez, Lara Gómez‐Labrador, Esteban Daudén   +11 more
wiley   +1 more source

Strategies and Behaviour Change Techniques to Optimise Sedentary Behaviour for People with Severe Asthma: A Nominal Group Technique. [PDF]

J Clin Med
Urroz Guerrero PD, McDonald VM, Gibson PG, Majellano EC, Lewthwaite H.   +4 more
europepmc   +1 more source

HPV‐6 Positive Eruptive Verruca Vulgaris After Upadacitinib Initiation for Severe Atopic Dermatitis

JEADV Clinical Practice, EarlyView.
ABSTRACT Oral JAK‐1 inhibitors for atopic dermatitis (AD) are associated with an increased risk of cutaneous viral infections, particularly herpes zoster. Emerging case reports further suggest a link to eruptive human papillomavirus (HPV) disease. A 23‐year‐old transgender man (female‐to‐male) with severe AD developed a rapidly disseminating eruption ...
Mohammed Shanshal, Emily Moon, Georgios Kallikas   +2 more
wiley   +1 more source

Bronchial thermoplasty for severe asthma: Systematic review and meta-analysis of benefits and harms. [PDF]

J Allergy Clin Immunol Glob
Rayner DG, Chu AWL, Cox G, Ologundudu L, Wong MM, Islam N, Bonta P, Shah PL, Slebos DJ, Annema J, Chu X, Chipps B, Oppenheimer J, Israel E, Rivera-Spoljaric K, Perry TT, Nyenhuis SM, Hoyte F, Sumino K, O'Byrne PM, Shade LE, Guyatt GH, Press VG, Rangel S, McCabe E, Melendez A, Sue-Wah-Sing D, Orr H, Gardner DD, Winders T, Przywara K, Rank MA, Mosnaim G, Bacharier LB, Chu DK.   +34 more
europepmc   +1 more source

Paradoxical Alopecia Areata Induced by IL‐17 and IL‐23 Inhibitors: A Systematic Review

JEADV Clinical Practice, EarlyView.
This systematic review identifies consistent clinical patterns of alopecia areata associated with IL‐17 and IL‐23 inhibitors, most frequently involving secukinumab and ustekinumab. Disease severity varied widely, and management often required biologic discontinuation or therapeutic switching.
Isabella Kamholtz, Simonetta I. Gaumond, Joaquin J. Jimenez   +2 more
wiley   +1 more source

Identification and validation of cilia-associated molecular candidates deregulated in severe asthma. [PDF]

Respir Res
Devilliers MA, Saber Cherif L, Brisebarre A, Chouquet R, Bralet L, Ancel J, Vivien A, Luczka-Majérus E, Bonnomet A, Lalun N, Taillé C, Dubernard X, Mérol JC, Ruaux C, Polette M, Deslée G, Perotin JM, Dormoy V.   +17 more
europepmc   +1 more source

Patient‐Centred Care in Atopic Dermatitis: Digital Communication, Misinformation, and Global Perspectives From the Pacecad Sessions (Isad Rajka Symposium, Melbourne 2025)

JEADV Clinical Practice, EarlyView.
ABSTRACT The PaCeCAD (Patient Centricity Care in Atopic Dermatitis) Sessions were held on Friday, October 24th, 2025, in Melbourne, Australia, as a conference‐format meeting during the first morning of the 15th Georg Rajka International Symposium on Atopic Dermatitis organized by the International Society of Atopic Dermatitis (ISAD).
Jean‐François Stalder, John C. Su, Fanny Sentenac, Mikael Alsterholm, Alpana Mohta, Hanof Ahmed, Pranvera Sulejmani, Kelly Barta, Kristin Bellenson, Fahafahantsoa Rapelanoro Rabenja, Tina Mesarič, Melanie Funk, Masaki Futamura, Kam Lun Ellis Hon, Kin Fon Leong, Laurent Elgard, David Troya, Alain Taïeb   +17 more
wiley   +1 more source

Comparative analysis of the manufacturing carbon footprint of biologics for severe asthma. [PDF]

BMJ Open
Taylor H, Rahman N.
europepmc   +1 more source

Deubiquitinase USP38 Stabilizes PLK1 Expression to Boost DNA Damage Repair in Ovarian Cancer

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Ovarian cancer (OC) is one of the most prevalent and severe gynecological malignant tumors. DNA damage repair (DDR) is essential in maintaining genome stability. This study aims to investigate the effects and mechanisms of USP38 and PLK1 on DNA damage repair and malignant behavior in OC cells.
Yuan Ma, Ying Li, Kai‐Li Li
wiley   +1 more source